wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38656760-22D4D2B1-80D5-4ACB-A07F-FB7CE5F5D80C
Q38656760-22D4D2B1-80D5-4ACB-A07F-FB7CE5F5D80C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38656760-22D4D2B1-80D5-4ACB-A07F-FB7CE5F5D80C
Targeted therapy for renal cell carcinoma: focus on 2nd and 3rd line.
P2860
Q38656760-22D4D2B1-80D5-4ACB-A07F-FB7CE5F5D80C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38656760-22D4D2B1-80D5-4ACB-A07F-FB7CE5F5D80C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5e32bc300adfa786d814a0055d43a63207ccde1
P2860
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma.